News Center
img
/
/
/
The National Medical Security Bureau replied: Centralized procurement of Chinese patent medicines is already on the way!

News Center

─  Specialized manufacturer  •  since 2005  ─

NEWS CENTER

The National Medical Security Bureau replied: Centralized procurement of Chinese patent medicines is already on the way!

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2022-01-07
  • Views:0

(Summary description)Recently, the National Medical Insurance Bureau issued the "Response of the National Medical Insurance Bureau to Recommendation No. 4126 of the Fourth Session of...

The National Medical Security Bureau replied: Centralized procurement of Chinese patent medicines is already on the way!

(Summary description)Recently, the National Medical Insurance Bureau issued the "Response of the National Medical Insurance Bureau to Recommendation No. 4126 of the Fourth Session of...

  • Categories:Industry News
  • Author:
  • Origin:
  • Time of issue:2022-01-07
  • Views:0
Information

Source|National Medical Security Bureau

Recently, the National Medical Insurance Bureau issued the "Response of the National Medical Insurance Bureau to Recommendation No. 4126 of the Fourth Session of the 13th National People's Congress" (medical insurance letter [2021] ] No. 28) (hereinafter referred to as "Reply").

The "Answer" clarified the direction of the next step on the basis of explaining the progress of centralized drug procurement.

The "Notice" pointed out that, in accordance with the decisions and deployments of the Party Central Committee and the State Council, the National Medical Insurance Bureau will work with relevant departments to promote the reform of the centralized drug procurement system in an orderly manner, and successfully carried out five batches of 218 drug centralized procurement.

At the same time, under the guidance and promotion of the National Medical Insurance Bureau, all the ** provinces across the country have carried out centralized drug procurement in the form of independent procurement or cross-provincial alliance procurement.

Concentrated procurement promises to give priority to the use of selected products and ensure the completion of the agreed procurement volume, giving companies stable market expectations, providing companies with a platform for fair competition in the sun, squeezing out the cost of intermediate circulation links, and competition among companies The focus of the original "rebate competition" to the competition of quality and price will help form a legal and market-oriented good business environment, and will also help increase industry concentration and promote high-quality development of the industry.

Regarding the proposal to allow Chinese patent medicines to enter the centralized drug procurement as soon as possible, and to allow more traditional Chinese medicine manufacturers to participate in the competition fairly, the "Notice" mentioned the "Opinions of the General Office of the State Council on Promoting the Normalization and Institutionalization of Centralized Drug Procurement Work" "(Guobanfa [2021] No. 2) clearly stated that "exploring the merger of different generic drugs with similar indications or functions and indications to carry out centralized and volume procurement" provides a basic follow for the centralized procurement of proprietary Chinese medicines.

At present, Qinghai Province, Jinhua in Zhejiang Province, Puyang in Henan Province and other places have carried out centralized procurement explorations for some Chinese patent medicines that are in high demand and high in value, and have achieved positive results.

In addition, the "Notice" also clearly pointed out that in the next step, the National Medical Insurance Bureau will work with relevant departments to improve the quality evaluation standards of Chinese patent medicines and formula granules, insist on quality first, oriented by clinical needs, and value-added Starting with the variety of products, scientifically and steadily promote the reform of centralized procurement of Chinese patent medicines and formula granules.

END

Scan the QR code to read on your phone

LATEST NEWS

Medica Expo in Düsseldorf 2021
Medica Expo in Düsseldorf 2021
Time of issue : 2022-04-14
Keewell Overseas Marketing Team has paticipated the MEDICA from 15 - 18 November 2021 despite the new wave of pandemic.
See more information
Keewell Overseas Marketing Team has paticipated the MEDICA from 15 - 18 November 2021 despite the new wave of pandemic.
Looking forward to seeing you in Shanghai CMEF 2022
Looking forward to seeing you in Shanghai CMEF 2022
Looking forward to your visit at Shanghai CMEF 2021
See more information
Looking forward to your visit at Shanghai CMEF 2021
Keewell wishing you a prosperous 2022
Keewell wishing you a prosperous 2022
Time of issue : 2022-04-14
Keewell wishing you a prosperous 2019
See more information
Keewell wishing you a prosperous 2019
Keewell exhibited at Medica Dusseldorf 13-16 Nov 2017
Keewell exhibited at Medica Dusseldorf 13-16 Nov 2017
For the third time, Keewell attended the Medica Dusseldorf to exhibite its specialized products line: Blood and Infusion Warmers. The FT series, which adapt the most advamced tube warming system...
See more information
For the third time, Keewell attended the Medica Dusseldorf to exhibite its specialized products line: Blood and Infusion Warmers. The FT series, which adapt the most advamced tube warming system...

Keewell Medical Technology Co., Ltd.

dingwei

Add: Xiananyi Industry Zone, Pingzhou,Nanhai District, Foshan City,Guangdong Province 528251, P.R.China

Copyright 2021@ Keewell Medical Technology Co., Ltd.  粤ICP备16061208号   www.300.cn SEO TAGS